Abstract library

442 results for "hepatic lesion".
#1061 Transcatheter Arterial Chemoembolization for Unresectable Metastatic Hepatic Lesions of Pancreatic Neuroendocrine Tumors
Introduction: The blood supply of metastatic hepatic neuroendocrine tumors is mainly supplied by hepatic arteries. For unresectable metastatic NETs, selective embolisation of the hepatic arteries may be therapeutic.
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - Others
Presenting Author: Bao Xin
Authors: Xin B, Lou W, Ji Y, Liu L X, ...
Keywords: pnet, hepatic lesion, tace
#1259 Expressions of ATRX and DAXX in Hepatic Metastatic Pancreatic Nonfunctional Neuroendocrine Neoplasms
Introduction: Loss of ATRX or DAXX is common in well-differentiated pancreatic neuroendocrine neoplasms, and is correlated with higher tumor stage and shorter survival time.
Conference: 13th Annual ENETS conference (2016)
Category: Biomarkers
Presenting Author: Bao Xin
Authors: Xin B, Lou W, Ji Y, Xie Y, ...
#76 Role of contrast-enhanced ultrasonography in the differential diagnosis of the pancreatic and hepatic lesions
Introduction: Contrast-enhanced ultrasonography (CEUS) is a new promising tool for the characterization of pancreatic lesions. This technique allows for highlighting the micro-vascularization of a lesion, especially with the use of second generation contrast media, characterized by harmonic responses at low acoustic pressures. Pancreatic endocrine tumors (PET)s were reported to have a peculiar behavior at CEUS, consisting of a higher enhancement compared to normal pancreas in the arterial phase and a rapid washout.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Francesco Milone
#563 Role of Ga-68 Somatostatin Receptor PET/CT in the Assessment of Response to Radiofrequency Ablation in Hepatic Metastases of Neuroendocrine Tumors
Introduction: Patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET) present frequently with hepatic metastases. Radiofrequency ablation (RFA) is an important local ablative treatment for hepatic metastases.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Prof. Dr. Richard P Baum
#1035 Liver Transplantation for Metastatic Hepatic Neuroendocrine Tumors of Unknown Origin
Introduction: Liver transplantation can be implemented on patients with diffuse hepatic tumors, but for hepatic NETs its role and value are still unclear.
Conference: 12th Annual ENETS Conference (2015)
Category: Surgical treatment
Presenting Author: Bao Xin
Authors: Xin B, Lou W, Ji Y, Zhou J, ...
Keywords: hepatic nets, lt
#1727 Ultrasonography Characteristics of Hepatic Neuroendocrine Neoplasm
Introduction: The incidence of hepatic neuroendocrine neoplasm (HNEN) is significantly increased in recent years.Lack of recognization usually lead to misdiagnosis.
Conference: 14th Annual ENETS conference (2017)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: house physician Xiaona Lin
Authors: Lin X, Chen J, Xu M, Xie X, ...
#1805 Application of Parametric Contrast-Enhanced Ultrasound for Early Treatment Response Evaluation in Metastatic Hepatic Neuroendocrine Neoplasm
Introduction: Since shrinkage of lesions in patients with metastatic hepatic neuroendocrine neoplasm (MHNEN) receiving systemic therapy is rarely observed,limit of RECIST for evaluating treatment response gradually emerged.
Conference: 14th Annual ENETS conference (2017)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: house physician Xiaona Lin
Authors: Lin X, Chen J, Xu M, Xie X, ...
#1258 Expressions of CK 19 and CD117 in Hepatic Metastatic Pancreatic Nonfunctional Neuroendocrine Neoplasms
Introduction: The expressions of CK19 and CD117 in pancreatic neoruendocrine neoplasms were considered dismal prognostic factors in some studies, but inconsistent in others.
Conference: 13th Annual ENETS conference (2016)
Category: Biomarkers
Presenting Author: Bao Xin
Authors: Xin B, Lou W, Ji Y, Xie Y, ...
Keywords: CK19, CD117, pNEN, LM, TMA
#2041 Hepatic Tumor Burden Can be Reduced Rapidly and Effectively by Trans-Arterial Embolization Combined with Systemic Therapy in Patients with Neuroendocrine Tumor Liver Metastasis (NETLM)
Introduction: The main tumor burden of patients with neuroendocrine tumor liver metastasis is comprised by hepatic lesions.
Conference: 15th Annual ENETS conference (2018)
Category: Imaging and Interventions (radiology, endoscopy)
Presenting Author: Yiming Liu
Authors: Liu Y, Wang Y, Lian F, Shen L, ...
#224 Primary Renal Somatostatinoma with Hepatic Metastases
Introduction: Somatostatinomas are rare gastroenteropancreatic neuroendocrine tumors (GEP-NET) with a primary lesion that is invariably localized to the pancreas (40%) or duodenum or jejunum (50%).
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr Richard W Carroll
Authors: Carroll R, Ghaffar A, Meeran K, Todd J, ...